Skip to main content
. 2022 May 19;27(9):751–759. doi: 10.1093/oncolo/oyac093

Table 2.

Summary of treatment and outcomes for pooled patient cohort.

Pooled cohort
Number of patients Results
Type of treatment, n (%) 41
 Chemotherapy alone 17 (41.5%)
 Radiation 1 (2.4%)
 Chemotherapy and radiation 4 (9.8%)
 No treatment 19 (46.3%)
Follow-up time, median (IQR) 42 8 weeks (9.5 weeks)
Overall survival time, median (IQR) 40 8 weeks (10 weeks)
 No treatment 18 4 weeks (9.3 weeks)
 Treatment 19 10.3 weeks (4.4 weeks)
Survival outcome, n (%) 45
 Alive 4 (8.9%)
 Death 41 (91.1%)
Cause of death, n (%) 18
 Hemorrhage related 11 (61.1%)
 Respiratory failure 4 (22.2%)
 Sepsis 1 (5.6%)
 Carcinomatosis 2 (11.1%)